< Back to previous page
Researcher
Bram Verstockt
- Disciplines:Gastro-enterology
Affiliations
- Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Oct 2015 → Today
Projects
1 - 10 of 12
- Inflammatory bowel diseasesFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Infrastructure for Targeted ProteomicsFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Characterization of triggers of post-operative recurrence in Crohn’s disease in both the external and luminal side of the intestineFrom1 Jan 2023 → TodayFunding: FWO research project
- Exploring the gut barrier as master regulator of microbiome-host interactions in CKD patients using organoid culturesFrom11 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Development of a gut-on-a-chip model for pre-clinical testing of drugs for inflammatory bowel diseaseFrom12 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Gastroenterology > Inflammatory Bowel disease > personalised medicine; biomarkers; multi-omicsFrom1 Jun 2022 → TodayFunding: BOF - various
- The role of myeloid cells in the resolution of intestinal inflammationFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The role of eosinophils in intestinal inflammation and fibrosis in inflammatory bowel disease.From5 Mar 2020 → 5 Mar 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- “Predicting response to therapy in inflammatory bowel diseases ”From23 Sep 2019 → 23 Sep 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Interaction Between Myeloid And Stromal Cells Dictates Disease Outcome in Intestinal InflammationFrom1 Oct 2018 → 27 Jun 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 200
- Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysis(2024)
Authors: Bram Verstockt
- Letter: Modifying the Mayo endoscopic subscore for improved prognostic insights. Authors' reply.(2024)
Authors: Matthias Lenfant, Bram Verstockt, João Guedelha Sabino, Séverine Vermeire, Marc Ferrante
Pages: 1007 - 1008 - Accuracy of Information given by ChatGPT for patients with Inflammatory Bowel Disease in relation to ECCO Guidelines.(2024)
Authors: Bram Verstockt
Pages: jjae040 - Letter: Should ulcerative colitis be monitored more or less invasively? Authors' reply(2024)
Authors: Matthias Lenfant, Bram Verstockt, João Guedelha Sabino, Séverine Vermeire, Marc Ferrante
Pages: 723 - 724 - Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel Disease.(2024)
Authors: Bram Verstockt, Marc Ferrante, João Guedelha Sabino, Jeroen Raes, Séverine Vermeire
Pages: 483 - 495 - Crohn's Patient Serum Proteomics Reveals Response Signature for Infliximab but not Vedolizumab(2024)
Authors: Bram Verstockt
- The assessment of segmental healing by the Modified Mayo Endoscopic Score (MMES) complements the prediction of long-term clinical outcomes in patients with ulcerative colitis(2024)
Authors: Matthias Lenfant, Bram Verstockt, João Guedelha Sabino, Séverine Vermeire, Marc Ferrante
Pages: 1 - 7 - Role of artificial intelligence in imaging and endoscopy for the diagnosis, monitoring and prognostication of inflammatory bowel disease: a scoping review protocol(2023)
Authors: Bram Verstockt
- Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study(2023)
Authors: Bram Verstockt, Peter Bossuyt
Pages: 1791 - 1799 - Treatment of Antibiotic Refractory Chronic Pouchitis With JAK Inhibitors and S1P Receptor Modulators: An ECCO CONFER Multicentre Case Series(2023)
Authors: Bram Verstockt
Patents
1 - 2 of 2